Meeting
2021 ASCO Annual Meeting
Immune checkpoint inhibitors (ICI) in advanced sarcomatoid renal cell carcinoma (sRCC): A multicenter study.
Authors
Dharmesh Gopalakrishnan
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Dharmesh Gopalakrishnan , Katharine Collier , Joseph J Park , Jacob P Zaemes , Elaine Tat Lam , Sabah Alaklabi , Ellen Jaeger , Rahul Atul Parikh , Pedro C. Barata , Eric Kauffman , Michael B. Atkins , Ajjai Shivaram Alva , Yuanquan Yang , Saby George
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 4568)
DOI
10.1200/JCO.2021.39.15_suppl.4568
Abstract #
4568
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma.
First Author: Alina Pascale
Poster
2023 ASCO Annual Meeting
Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-cell lung cancer.
First Author: Jarushka Naidoo
Poster
2023 ASCO Annual Meeting
Pan tumor outcomes to immune checkpoint inhibitors in patients of Native American origin in the United States: The multicenter POINT-US study.
First Author: Minh Duc Phan
Poster
2022 ASCO Genitourinary Cancers Symposium
Systemic therapy in patients with metastatic Xp11.2 translocation renal cell carcinoma.
First Author: Xieqiao Yan